Evidence map›Paper›PMID 18029455›Full record

ArticleThe Journal of clinical endocrinology and metabolism2008

Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men.

Sebastiaan Hammer, Rutger W van der Meer, Hildo J Lamb, Michael Schär, Albert de Roos, Jan W A Smit, Johannes A Romijn

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01761318 (Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus), which is not on this map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01761318 phase4completedstarted 2013, after this paper: background citation

Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus

Ran2013Enrolled50Registered outcomes48Posted comparisons0ConditionsCardiovascular Disease, Diabetes Mellitus Type 2, Diastolic Dysfunction, Fatty LiverArmsliraglutide, Liraglutide - Placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Effects of short-term hypercaloric nutrition on orthostatic tolerance in healthy individuals: a randomized controlled crossover study.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2022
    Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Lipotoxicity: a driver of heart failure with preserved ejection fraction?Clinical science (London, England : 1979) · 2021
    Review
  14. Comparison of single-voxelJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2021
    Article
  15. Review
  16. Article
  17. Mitochondrial NADAntioxidants & redox signaling · 2019
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sebastiaan HammerDepartment of Endocrinology and Metabolism (C4-R), Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. S.Hammer@LUMC.nl
Rutger W van der Meer
Hildo J Lamb
Michael Schär
Albert de Roos
Jan W A Smit
Johannes A Romijn
Leiden University Medical Center · NLPhilips (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextIn animal experiments, high plasma concentrations of free fatty acids (FFAs) are associated with increased triglyceride (TG) stores in liver and heart, and impaired cardiac function. In humans caloric restriction increases plasma FFA levels.

objectiveOur objective was to assess the effects of progressive caloric restriction on myocardial and hepatic TG content and myocardial function.

designThis was a prospective intervention study.

participantsThis study included 10 lean healthy men.

interventionsThree-day partial (471 kcal/d) and complete starvation was performed. OUTCOME MEASURES: Plasma levels of FFA, myocardial and hepatic TG content, and myocardial function were calculated.

resultsPlasma FFA increased from 0.6 +/- 0.4 mmol/liter to 1.2 +/- 0.4 and to 1.9 +/- 0.7 mmol/liter, after partial and complete starvation, respectively (P < 0.001). Myocardial TG content increased from 0.35 +/- 0.14% to 0.59 +/- 0.27%, and 1.26 +/- 0.49%, respectively (P < 0.01). The ratio between the early diastole and atrial contraction decreased from 2.2 +/- 0.4 to 2.1 +/- 0.4 (P = 0.7) and 1.8 +/- 0.4, respectively (P < 0.01), and diastolic early deceleration from 3.4 +/- 0.7 ml/sec(2) x 10(-3) to 2.9 +/- 0.5 and 2.8 +/- 0.9 ml/sec(2) x 10(-3), respectively (P < 0.05). Hepatic TG content decreased after partial starvation (from 2.23 +/- 2.24% to 1.43 +/- 1.33%; P < 0.05) but did not change upon complete starvation.

conclusionsProgressive caloric restriction induces a dose-dependent increase in myocardial TG content and a dose-dependent decrease in diastolic function in lean healthy men. Hepatic TG content showed a differential response to progressive caloric restriction, indicating that redistribution of endogenous TG stores is tissue specific.

Indexed as

Caloric RestrictionAdultBlood GlucoseBlood PressureCholesterolCohort StudiesFatty Acids, NonesterifiedHeart RateHumansInsulinLiverMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMaleMyocardiumProspective StudiesBlood GlucoseCholesterolFatty Acids, NonesterifiedInsulinTriglycerides

Identifiers

PMID18029455
OpenAlexW2154543391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.